Baclofen-Associated Neurophysiologic Target Engagement Across Species in Fragile X Syndrome

Background: Fragile X Syndrome (FXS) is the most common inherited form of neurodevelopmental disability. It is often characterized, especially in males, by intellectual disability, anxiety, repetitive behavior, social communication deficits, delayed language development and abnormal sensory processing. Recently, we identified electroencephalographic (EEG) biomarkers that are conserved between the mouse model of FXS (Fmr1 KO mice) and humans with FXS. Methods: In this report, we evaluate small molecule target engagement utilizing multielectrode array electrophysiology in the Fmr1 KO mouse and in humans with FXS. Neurophysiologic target engagement was evaluated using single doses of the GABAB selective agonist racemic baclofen (RBAC). Results: In Fmr1 KO mice and in humans with FXS, baclofen use was synchronously associated with suppression of elevated gamma power and increase in theta power at rest. In the Frm1 KO mice, a baclofen-associated improvement in auditory chirp synchronization was also noted. Conclusions: Overall, we noted synchronized target engagement of RBAC on resting state electrophysiology, in particular the reduction of aberrant high frequency gamma activity, across species in FXS. This finding holds promise for translational medicine approaches to drug development for FXS, synchronizing treatment study across species using well-established EEG biological markers in this field. Trial Registration: The human experiments are registered under NCT02998151.

Random heterogeneity outperforms design in network synchronization

A widely held assumption on network dynamics is that similar components are more likely to exhibit similar behavior than dissimilar ones and that generic differences among them are necessarily detrimental to synchronization. Here, we show that this assumption does not generally hold in oscillator networks when communication delays are present. We demonstrate, in particular, that random parameter heterogeneity among oscillators can consistently rescue the system from losing synchrony. This finding is supported by electrochemical-oscillator experiments performed on a multielectrode array network. Remarkably, at intermediate levels of heterogeneity, random mismatches are more effective in promoting synchronization than parameter assignments specifically designed to facilitate identical synchronization. Our results suggest that, rather than being eliminated or ignored, intrinsic disorder in technological and biological systems can be harnessed to help maintain coherence required for function.